Gemina Laboratories Ltd.
GLABF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40 | $75 | $47 | $29 |
| - Cash | -$0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $41 | $75 | $48 | $30 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | -6,358.2% | – | – |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | -6,994.2% | – | – |
| EPS Diluted | -0.004 | -0.01 | -0.019 | -0.012 |
| % Growth | 62.5% | 46.4% | -64.4% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |